Home

domestiquer traiter avec navigateur Pulls sanofi Dans le nom se cramponner Sudouest

Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form  6-target R&D pact | Fierce Biotech
Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form 6-target R&D pact | Fierce Biotech

Sanofi Trial Failure Halts Work on Breast Cancer Treatment Amcenestrant
Sanofi Trial Failure Halts Work on Breast Cancer Treatment Amcenestrant

Sanofi pulls out of late-phase Daiichi vaccine collaboration | Fierce  Biotech
Sanofi pulls out of late-phase Daiichi vaccine collaboration | Fierce Biotech

Over-the-counter heartburn drug Zantac pulled in US, Canada | WPBN
Over-the-counter heartburn drug Zantac pulled in US, Canada | WPBN

ConAgra, Roche, Sanofi-Aventis and RadioShack Pull Advertisements from Fox  News Channel's Glenn Beck | Color Of Change
ConAgra, Roche, Sanofi-Aventis and RadioShack Pull Advertisements from Fox News Channel's Glenn Beck | Color Of Change

Lexicon slumps after Sanofi pulls out of deal
Lexicon slumps after Sanofi pulls out of deal

Sanofi raises profit forecast following positive Q2 results - PMLiVE
Sanofi raises profit forecast following positive Q2 results - PMLiVE

Sanofi pulls Zantac from US, Canada; FDA slams Chinese API manufacturer;  DMF guidance update | Radio Compass Blog
Sanofi pulls Zantac from US, Canada; FDA slams Chinese API manufacturer; DMF guidance update | Radio Compass Blog

Sanofi Might Pull Down Shutters For Two Vaccine Plants In India
Sanofi Might Pull Down Shutters For Two Vaccine Plants In India

Sanofi pulls out patent plea for TB drug in EU, but not in India - Times of  India
Sanofi pulls out patent plea for TB drug in EU, but not in India - Times of India

Sanofi improves workforce insights with real-time data across the globe.
Sanofi improves workforce insights with real-time data across the globe.

Sanofi to pull the plug on mRNA Covid-19 vaccine after rivals' success
Sanofi to pull the plug on mRNA Covid-19 vaccine after rivals' success

Sanofi stock falls as breast cancer drug amcenestrant development stopped  as trial fails | Seeking Alpha
Sanofi stock falls as breast cancer drug amcenestrant development stopped as trial fails | Seeking Alpha

BioCentury - After latest clinical disappointment, Sanofi pulls plug on SERD
BioCentury - After latest clinical disappointment, Sanofi pulls plug on SERD

Reaction 'excessive' to Sanofi's upcoming litigation: analysts
Reaction 'excessive' to Sanofi's upcoming litigation: analysts

Sanofi pulls out of mRNA COVID vaccine development - TeleTrader.com
Sanofi pulls out of mRNA COVID vaccine development - TeleTrader.com

Sanofi, Regeneron's Praluent pulls off PCSK9 coup with 29% cut to death  risks in most vulnerable patients | Fierce Pharma
Sanofi, Regeneron's Praluent pulls off PCSK9 coup with 29% cut to death risks in most vulnerable patients | Fierce Pharma

Sanofi pulls out of Dagenham | Pharmafile
Sanofi pulls out of Dagenham | Pharmafile

Sanofi Strategy Under CEO Paul Hudson: Capital Markets Day Slides
Sanofi Strategy Under CEO Paul Hudson: Capital Markets Day Slides

Sanofi pulls Lyxumia's US filing - PMLiVE
Sanofi pulls Lyxumia's US filing - PMLiVE

Sanofi quietly pulls the plug on its Zika vaccine project - STAT
Sanofi quietly pulls the plug on its Zika vaccine project - STAT

Sanofi pulls phase 3 trial of $3.7B drug as competition heats up
Sanofi pulls phase 3 trial of $3.7B drug as competition heats up